TCL Archive Pharmacia Says SU5416 Doesn’t Benefit Colorectal Cancer Patients, Closes Trial. March 1, 2002
TCL Archive Conversation with The Cancer Letter: Einhorn: “I Still Harbor Hope For Similar Success Stories” October 24, 2014
TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive Cuts From NCI Budget total $38 Million; Prevention Gets $21 Million Increase January 24, 1992
